Gene therapy for hemophilia delayed until 2022 after FDA rejects one-time treatment, shocking doctors and scientists | Genetic Literacy Project

Gene therapy for hemophilia delayed until 2022 after FDA rejects one-time treatment, shocking doctors and scientists | Genetic Literacy Project

Human Genetics

---

Gene therapy for hemophilia delayed until 2022 after FDA rejects one-time treatment, shocking doctors and scientists

Linda Johnson, Ricki Lewis

Viewpoint: Media focus on COVID-19 deaths ignores lasting impact of ‘calamitous pandemic’

Henry Miller, Josh Bloom

Viewpoint: ‘Health impact of chemicals doubled in last 5 years’? Gullible media misreporting flawed studies mislead the public

Geoffrey Kabat

Viewpoint: Is there a scientific basis to ban gene drive technology that can rid us of virus-carrying rodents and mosquitoes?

Kostas Vavitsas